ClearCharge — self-pay price estimator for surgery centers

1. One-liner

Turns an ASC’s fee schedule into an embeddable cash-price quote and an auto-built Good Faith Estimate that keeps it compliant.

2. Trend signal — why now?

The regulatory clock just changed shape. CMS’s CY2026 OPPS/ASC Final Rule (CMS-1834-FC, released Nov 21 2025) overhauls price transparency, and the part that matters for a small surgery center is the enforcement teeth: the new requirements take effect Jan 1 2026 with enforcement starting April 1 2026, and CMS dropped the old “warning notice first” courtesy — for facilities that made no attempt to comply, it now goes straight to a corrective action plan on a 90-day clock, with civil monetary penalties for the core failures (no machine-readable file, no shoppable-services display). Crucially, CMS explicitly lets a facility satisfy the shoppable-services requirement with an internet price-estimator tool instead of a static file. That single line turns a compliance chore into a buildable product.

Stack the No Surprises Act on top. CMS is not deferring enforcement of Good Faith Estimates for uninsured and self-pay patients, with civil penalties up to $10,000 per violation. Every scheduled self-pay case legally needs a written, itemized estimate before service. So an ASC now has two overlapping obligations — a public shoppable-price display and a per-patient GFE — and both are the same underlying data problem: take my chargemaster, turn it into a number a human can act on.

Why an ASC and not a hospital: hospitals already bought enterprise transparency vendors. ASCs didn’t — and there are a lot of them. Roughly 6,200 Medicare-certified ASCs (Definitive Healthcare), ~10,200 freestanding centers total, and about 92% are physician-owned with ~65% wholly independent (Colliers Q3 2025). These are SMB-scale operators who compete on cash price — an independent center’s surgery or MRI routinely runs 50–80% less than the hospital across the street (DirectMedicine) — and self-pay patients increasingly call around to shop. Price transparency for them isn’t just compliance; it’s the marketing weapon. That’s the wedge: the same tool that keeps them off CMS’s penalty list also wins them the shopping patient.

Provenance:

• Signal 1 (Demand/Regulatory): CY2026 OPPS/ASC Final Rule — shoppable-services satisfiable via internet price-estimator; enforcement starts Apr 1 2026, no warning notice, 90-day CAP — https://www.cms.gov/newsroom/fact-sheets/cy-2026-opps-ambulatory-surgical-center-final-rule-hospital-price-transparency-policy-changes — 2026-06
• Signal 2 (Feasibility): Cheap long-context LLMs turn a CPT/chargemaster fee schedule into consumer-language cash quotes + itemized No-Surprises-Act GFEs; estimator is now an allowed compliance method — https://www.hklaw.com/en/insights/publications/2025/11/cms-releases-cy-2026-hospital-opps-and-ambulatory-surgical-center — 2026-06
• Signal 3 (Economic): ~6,200 Medicare-certified ASCs (~10,200 freestanding), ~92% physician-owned/~65% wholly independent; cash prices 50–80% below hospitals make transparency a growth lever — https://www.definitivehc.com/blog/how-many-ascs-are-in-the-us — 2026-06 Category: Regulatory arbitrage

3. The opportunity

The price-transparency vendor market was built for hospitals — Turquoise Health, Panacea, hospital RCM suites — priced and scoped for systems with a compliance department and a chargemaster analyst. They center the machine-readable file (the part regulators read) and treat the patient-facing estimator as an afterthought.

An independent ASC has none of that. It has an office manager who also runs scheduling, a fee schedule in a spreadsheet or buried in the practice-management system, and now a federal deadline plus a $10K-per-GFE-violation exposure. What it actually wants is dead simple: a page on its website where a patient picks “knee arthroscopy” or “screening colonoscopy,” sees an honest all-in cash price in ten seconds, and — if they book — gets a compliant Good Faith Estimate PDF in their inbox without anyone hand-typing CPT codes.

The 10× isn’t a fancier MRF. It’s collapsing the two-hour, error-prone “build me an estimate” task the front desk does manually into a self-serve widget, and doing it at a price an SMB will actually pay. The incumbents won’t chase 10,000 sub-$30M centers one at a time with a self-serve product; that’s the gap.

4. Target market

• Primary customer: Practice administrator / billing manager at an independent, physician-owned ASC or freestanding surgical/imaging center (US, typically 2–6 ORs or 1–3 imaging modalities, $3M–$30M revenue). Secondary: cash-pay specialty clinics (orthopedic, GI, ophthalmology, dermatology) and direct-pay imaging centers facing the same GFE obligation.
• Why they buy: “I have a federal deadline in April, a $10K-per-violation GFE rule already live, and a front desk that builds estimates by hand and gets them wrong. The hospital tools quoted me five figures. I just need a price page and a GFE button that won’t get me fined.”
• Rough TAM reasoning: ~6,200 Medicare-certified ASCs + thousands of freestanding imaging and cash-pay surgical centers. If even 6,000 are independent and addressable at ~$200/mo, that’s a ~$14M ARR ceiling on ASCs alone — before imaging centers and DPC-adjacent clinics. Comfortably a sub-$5M bootstrap target, too small to interest the hospital-grade vendors.
• Why now for them: April 1 2026 enforcement with no warning notice; GFE penalties already live; and self-pay patients are shopping cash prices harder than ever, so the estimator pays for itself as a booking tool, not just a compliance cost.

5. Product sketch (MVP)

• Upload a fee schedule / chargemaster (CSV, PDF, or paste) — the tool maps line items to CPT/HCPCS and proposes consumer-friendly procedure names.
• A branded, embeddable price-estimator widget for the center’s website: patient picks a procedure, answers 2–3 questions (insured vs. self-pay, facility-only vs. bundled), gets an all-in estimate with a plain-language breakdown.
• One-click Good Faith Estimate generation: itemized, NSA-compliant PDF with required disclaimers, dispute-rights language, and provider/expected-charge fields, logged with a timestamp for audit.
• A shoppable-services display page (the 70 CMS-specified + center-selected services) that satisfies the consumer-friendly requirement, kept in sync with the fee schedule.
• Estimate log / audit trail: every quote and GFE stored, exportable, so the center can show CMS it did the work.
• “Plain-English rewrite” of clinical line items so a patient sees “anesthesia for your procedure,” not a raw CPT string.
• Optional financing hand-off: surface CareCredit/Scratchpay/Cherry links on the estimate so a sticker-shocked patient has a next step.

6. AI angle — what’s load-bearing

Remove the AI and this is a glorified spreadsheet form. The load-bearing work is exactly the part humans are slow and inconsistent at: reading a messy, center-specific chargemaster (every ASC names things differently, bundles differently, and mixes facility/professional/anesthesia/implant lines) and turning it into (a) correctly mapped CPT/HCPCS codes, (b) consumer-language procedure names, and (c) an itemized estimate that survives a No Surprises Act audit. That’s a long-context reading-and-normalization task that only became cheap and reliable in the last 12–18 months. The GFE itself has required legal language and structure the model assembles per-case. The estimator’s “what will this actually cost me” logic — bundling the right line items for a given procedure — is the model’s job, supervised by the center’s confirmation.

7. Localization angle (if any)

N/A — this is a US-only play by construction. The entire opportunity is the CY2026 CMS rule plus the No Surprises Act; both are US-specific federal regimes with US-specific CPT/HCPCS coding and dollar penalties. A “localized” version is meaningless here — the regulation is the product surface. (A future analog could exist wherever another country mandates self-pay price disclosure, but that’s a different idea, not a localization of this one.)

8. Business model — path to $1M–$5M ARR

• Pricing: $149/mo (single-facility, estimator + GFE + shoppable display) → $349/mo (multi-modality / higher volume, audit log, financing integrations). Optional one-time $499 chargemaster-onboarding/mapping fee to fund the high-touch first import.
• ACV: ~$2,400–$4,200/yr realistic blended.
• Rough math to $1M ARR: ~350 centers × ~$240/mo avg × 12 ≈ $1.0M. That’s ~6% of the ~6,200-center Medicare-certified base — believable for a focused operator over 18–24 months.
• Rough math to $5M ARR: ~1,500 centers across ASCs + freestanding imaging + cash-pay specialty clinics, plus an upsell tier and the onboarding fees. Requires expanding beyond ASCs into imaging/DPC and a repeatable, partly self-serve onboarding — plausible but the harder half.
• Expansion path: per-facility seats for multi-site operators; add patient pre-collection / deposit capture on the estimate (take a card at quote time); financing-referral revenue share; “estimate accuracy / denial” analytics as a higher tier.

9. Go-to-market wedge — first 100 customers

• ASCA + state-association member directories are public. Scrape the state-by-state ASC lists (ASC Association publishes them), filter to independent/physician-owned, pull the website, and check whether they currently expose any price page. Cold-email the administrator a 90-second Loom showing their own center with a working estimator and a sample GFE pre-built from a guessed fee schedule. “Here’s your compliance page, live, in two minutes.” Personalized + deadline-driven → expect a strong reply rate on a base of a few thousand.
• Ride the April 1 2026 enforcement date. Run a “Are you ready for ASC price-transparency enforcement?” free compliance checker that scans a center’s website for an MRF + shoppable display and emails a red/green report. The non-compliant list becomes the sales pipeline.
• Partner with ASC billing/RCM consultants and management companies. They advise dozens of independent centers and are already the trusted “are we compliant?” voice; a referral/reseller cut puts ClearCharge in front of clustered, pre-qualified buyers.
• Financing vendors (Scratchpay, Cherry) as channel. They sit in thousands of these centers and benefit when a transparent estimate surfaces their product — co-marketing is mutually self-interested.

10. Build complexity — justification

Medium. The web app, the embeddable widget, and the PDF/GFE generation are standard off-the-shelf stack. The genuine work is the chargemaster-ingestion-and-mapping pipeline (messy inputs, CPT/HCPCS normalization, human-in-the-loop confirmation) and getting the GFE/shoppable-display formats exactly right against the CMS spec — that’s domain detail, not research. A technical founder with an ASC-billing advisor ships a credible v1 in ~10–14 weeks; the regulatory-correctness review is the long pole, not the engineering.

11. Gating checklist

Gate	Pass?	Note
Legal in target market	✅	Tool helps meet federal requirements; no licensure needed.
Ethical — no harm / dark patterns	✅	Pushes honest, upfront pricing — the opposite of a dark pattern.
Market exists (evidence above)	✅	~6,200 ASCs, live federal deadline + active GFE penalties.
1–5 person team can build this	✅	Standard stack + one domain advisor.
Launchable with <$50K / ₹40L	✅	Solo/pair build; no capital-heavy components.

All five pass.

12. Feasibility score

Axis	Weight	Score	Notes
Problem intensity	20	15/20	Real and now deadline-forced ($10K GFE penalties live; April 2026 enforcement). Not quite daily-bleeding for every center, but compliance fear + lost shopping patients is sharp.
Demand evidence	15	12/15	Hard regulatory mandate, documented cash-shopping behavior, existing (hospital-priced) vendor spend. Direct ASC-owner verbatim complaints were thin in research — docked for that.
Build feasibility	15	12/15	Standard stack; the chargemaster pipeline + CMS-format correctness is the only real effort. ~10–14 wks.
Distribution clarity	15	11/15	Named public directories + deadline hook + consultant channel. Conversion on cold email to busy administrators is the uncertainty.
Revenue mechanics	15	12/15	Compliance = budget line; pricing well below hospital tools; clear $1M path at ~6% penetration.
Time to first revenue	10	7/10	Compliance urgency shortens the cycle, but ASC procurement isn’t instant; 6–10 weeks to first paid pilot.
Defensibility	10	5/10	Moat is regulatory know-how + accumulated chargemaster mappings + workflow lock-in. Copyable, but enforcement-window timing favors first focused mover.
Total	100	74/100

13. Qualitative modifiers

Founder-fit tags

technical-heavy · domain-expertise-required — needs someone who can build the ingestion pipeline AND an advisor who knows ASC billing and the exact CMS/NSA formatting requirements cold.

Key assumptions to validate (3–5)

1. Assumption: Independent ASC administrators see April 2026 enforcement as a real, near-term threat (not “we’ll deal with it if audited”). How to test: 25–30 cold calls/emails to administrators; measure how many already know the date and are actively shopping a fix.
2. Assumption: They’ll pay ~$150–$350/mo rather than have their RCM vendor bolt it on for free. How to test: Offer a paid pilot to 10; track conversion and the “my biller already covers this” objection rate.
3. Assumption: Chargemaster ingestion can be made reliable enough that mapping is confirm-not-build for the admin. How to test: Run 15 real fee schedules through the pipeline; measure % line items auto-mapped correctly before human edit.
4. Assumption: The estimator measurably helps win shopping patients (so it’s revenue, not just cost). How to test: Instrument widget usage at 5 pilots; correlate quotes-viewed with booked self-pay cases.

Risk flags

1. Regulatory risk: CMS could shift the enforcement date or method again (the hospital side has already seen delays). If the deadline slips far, urgency — the core wedge — softens.
2. Platform/channel dependency: RCM and PM-software vendors could ship a “good enough” estimator as a free feature, commoditizing the standalone tool. Counter by being multi-PM-agnostic and owning the patient-facing UX they won’t.
3. Accuracy liability: A wrong GFE or estimate has legal/financial consequences for the center. The product must frame outputs as center-confirmed and keep a defensible audit trail; over-promising “automatic compliance” is a trap.

14. Structured verdict

Score:                  74/100
Verdict:                GO
Confidence:             Medium
Best-fit builder:       Technical founder + ASC-billing/compliance advisor
Time to revenue:        6–10 weeks (compliance-deadline-driven pilots)
Capital to launch:      $8–15K ($ for the high-touch first onboardings + infra)
Top 3 assumptions to validate first:
  1. Administrators treat April 2026 enforcement as urgent — 30 discovery calls
  2. WTP $150–350/mo over RCM-bundled "free" — 10 paid pilots, track objection rate
  3. Chargemaster auto-mapping accuracy high enough to be confirm-not-build — 15 real fee schedules
Kill criteria:
  - Abandon if <20% of 30 administrators see the deadline as a fundable near-term priority
  - Abandon if RCM/PM incumbents ship a free in-product estimator before v1 ships
  - Abandon if auto-mapping accuracy stays <70% on real chargemasters after iteration

15. Next step — 1-week validation sprint

• Day 1–2: Pull the public ASC Association state directories; build a list of 60 independent, physician-owned centers and check each website for an existing price page / MRF. Sort into “non-compliant” (hot) and “compliant” (cold).
• Day 3–4: Mock up the estimator on three real centers using their published or guessed fee schedules; record a personalized Loom per center. Send 30 cold emails with the deadline hook and the live demo.
• Day 5: Decide go / no-go on a falsifiable bar: ≥6 of 30 administrators reply requesting a demo or pilot AND ≥2 explicitly cite the April 2026 deadline as a reason. Below that, the urgency thesis is wrong and the idea waits.